King's College London

Research portal

Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant

Research output: Contribution to journalArticlepeer-review

Standard

Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant. / Borowiec, Blanka Maria; Volponi, Ana Angelova; Mozdziak, Paul et al.

In: Cells, Vol. 10, No. 12, 3383, 12.2021.

Research output: Contribution to journalArticlepeer-review

Harvard

Borowiec, BM, Volponi, AA, Mozdziak, P, Kempisty, B & Dyszkiewicz-Konwińska, M 2021, 'Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant', Cells, vol. 10, no. 12, 3383. https://doi.org/10.3390/cells10123383

APA

Borowiec, B. M., Volponi, A. A., Mozdziak, P., Kempisty, B., & Dyszkiewicz-Konwińska, M. (2021). Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant. Cells, 10(12), [3383]. https://doi.org/10.3390/cells10123383

Vancouver

Borowiec BM, Volponi AA, Mozdziak P, Kempisty B, Dyszkiewicz-Konwińska M. Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant. Cells. 2021 Dec;10(12). 3383. https://doi.org/10.3390/cells10123383

Author

Borowiec, Blanka Maria ; Volponi, Ana Angelova ; Mozdziak, Paul et al. / Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant. In: Cells. 2021 ; Vol. 10, No. 12.

Bibtex Download

@article{4bb18900eb8347cc924969b4c13bf747,
title = "Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant",
abstract = "The COVID-19 pandemic is a global challenge, demanding researchers address different approaches in relation to prevention, diagnostics and therapeutics. Amongst the many tactics of tackling these therapeutic challenges, small extracellular vesicles (sEVs) or exosomes are emerging as a new frontier in the field of ameliorating viral infections. Exosomes are part of extracellular vesicles (EVs)—spherical biological structures with a lipid bilayer of a diameter of up to 5000 nm, which are released into the intercellular space by most types of eukaryotic cells, both in physiological and pathological states. EVs share structural similarities to viruses, such as small size, common mechanisms of biogenesis and mechanisms for cell entry. The role of EVs in promoting the viral spread by evading the immune response of the host, which is exhibited by retroviruses, indicates the potential for further investigation and possible manipulation of these processes when tackling the spread and treatment of COVID-19. The following paper introduces the topic of the use of exosomes in the treatment of viral infections, and presents the future prospects for the use of these EVs.",
keywords = "COVID-19, Exosomes, Extracellular vesicles, SARS-CoV-2",
author = "Borowiec, {Blanka Maria} and Volponi, {Ana Angelova} and Paul Mozdziak and Bartosz Kempisty and Marta Dyszkiewicz-Konwi{\'n}ska",
note = "Funding Information: Funding: This research was in part supported by the National Institute of Food and Agriculture, United States Department of Agriculture Animal Health NC07082. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = dec,
doi = "10.3390/cells10123383",
language = "English",
volume = "10",
journal = "Cells",
issn = "2073-4409",
publisher = "MDPI",
number = "12",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Small extracellular vesicles and covid19—using the “trojan horse” to tackle the giant

AU - Borowiec, Blanka Maria

AU - Volponi, Ana Angelova

AU - Mozdziak, Paul

AU - Kempisty, Bartosz

AU - Dyszkiewicz-Konwińska, Marta

N1 - Funding Information: Funding: This research was in part supported by the National Institute of Food and Agriculture, United States Department of Agriculture Animal Health NC07082. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/12

Y1 - 2021/12

N2 - The COVID-19 pandemic is a global challenge, demanding researchers address different approaches in relation to prevention, diagnostics and therapeutics. Amongst the many tactics of tackling these therapeutic challenges, small extracellular vesicles (sEVs) or exosomes are emerging as a new frontier in the field of ameliorating viral infections. Exosomes are part of extracellular vesicles (EVs)—spherical biological structures with a lipid bilayer of a diameter of up to 5000 nm, which are released into the intercellular space by most types of eukaryotic cells, both in physiological and pathological states. EVs share structural similarities to viruses, such as small size, common mechanisms of biogenesis and mechanisms for cell entry. The role of EVs in promoting the viral spread by evading the immune response of the host, which is exhibited by retroviruses, indicates the potential for further investigation and possible manipulation of these processes when tackling the spread and treatment of COVID-19. The following paper introduces the topic of the use of exosomes in the treatment of viral infections, and presents the future prospects for the use of these EVs.

AB - The COVID-19 pandemic is a global challenge, demanding researchers address different approaches in relation to prevention, diagnostics and therapeutics. Amongst the many tactics of tackling these therapeutic challenges, small extracellular vesicles (sEVs) or exosomes are emerging as a new frontier in the field of ameliorating viral infections. Exosomes are part of extracellular vesicles (EVs)—spherical biological structures with a lipid bilayer of a diameter of up to 5000 nm, which are released into the intercellular space by most types of eukaryotic cells, both in physiological and pathological states. EVs share structural similarities to viruses, such as small size, common mechanisms of biogenesis and mechanisms for cell entry. The role of EVs in promoting the viral spread by evading the immune response of the host, which is exhibited by retroviruses, indicates the potential for further investigation and possible manipulation of these processes when tackling the spread and treatment of COVID-19. The following paper introduces the topic of the use of exosomes in the treatment of viral infections, and presents the future prospects for the use of these EVs.

KW - COVID-19

KW - Exosomes

KW - Extracellular vesicles

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85120319675&partnerID=8YFLogxK

U2 - 10.3390/cells10123383

DO - 10.3390/cells10123383

M3 - Article

AN - SCOPUS:85120319675

VL - 10

JO - Cells

JF - Cells

SN - 2073-4409

IS - 12

M1 - 3383

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454